12:00 AM
 | 
Jun 18, 2012
 |  BC Week In Review  |  Company News  |  Deals

Astex Pharmaceuticals, J&J deal

Astex received a £3.5 million ($5.4 million) milestone payment from Johnson & Johnson under a 2008 deal granting the pharma exclusive, worldwide rights to develop...

Read the full 104 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >